Who Owns Liminatus Pharma Stock?
NASDAQ: LIMNHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
Market open · Delayed 15 min · as of Oct 9, 10:15 AM ET
Ownership breakdown
- Held by institutions
- 1.41%
- Held by insiders
- 27.18%
- Institutional holders
- 14
- Institutions 1.4%
- Insiders 27.2%
- Public and other 71.4%
Who owns Liminatus Pharma stock?
Institutional investors own about 1.4% of Liminatus Pharma's shares, spread across 14 institutions that file 13F reports. That level of institutional ownership is relatively low, leaving more of the stock with retail investors and insiders. Insiders, including executives, directors and large founding shareholders, hold 27.18% of LIMN.
The largest institutional holders are Cygnus Capital Advisors, LLC (0.49%), Xtx Topco Ltd (0.33%) and Geode Capital Management, LLC (0.21%). Together, the top 10 institutions control 1.4% of shares outstanding. In their latest filings, 4 of the top 10 institutions increased their LIMN positions and 3 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of LIMN
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Cygnus Capital Advisors, LLC | 6.59K | 0.49% | -5.9% |
| Xtx Topco Ltd | 4.44K | 0.33% | +100.0% |
| Geode Capital Management, LLC | 2.77K | 0.21% | +17.5% |
| Citadel Advisors Llc | 1.12K | 0.08% | -91.7% |
| Vanguard Capital Management LLC | 1.01K | 0.08% | 0.0% |
| Goldman Sachs Group Inc | 804 | 0.06% | +100.0% |
| Stonex Group Inc. | 521 | 0.04% | +100.0% |
| Vanguard Fiduciary Trust Co | 460 | 0.03% | 0.0% |
| State Street Corporation | 380 | 0.03% | 0.0% |
| UBS Group AG | 335 | 0.02% | -69.3% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of LIMN
| Fund | Shares | % Held |
|---|---|---|
| Fidelity Concord Street Trust-Fidelity Extended Market Index Fund | 2.41K | 0.18% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 1.01K | 0.08% |
| Fidelity Concord Street Trust-Fidelity Total Market Index Fund | 162 | 0.01% |
| Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund | 124 | 0.01% |
Frequently asked questions
Who is the largest shareholder of Liminatus Pharma?
Cygnus Capital Advisors, LLC is the largest institutional shareholder of LIMN, owning 0.49% of shares outstanding (6.59K shares) as of its latest 13F filing.
What percentage of Liminatus Pharma is owned by institutions?
Institutions own about 1.4% of LIMN shares and 1.9% of the public float.
How much of Liminatus Pharma do insiders own?
Insiders, such as officers and directors, own about 27.18% of LIMN shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.